Rachel Abrams concentrates her practice in product liability and mass tort cases, typically involving consumer fraud and false advertising of dangerous or defective products. She has worked extensively on pharmaceutical mass tort litigation including, Breast Implant, DES, Fen-Phen, Sulzer-Hip Implants, Medtronic-AneuRx, Guidant-Ancure, Zyprexa, Seroquel, Medtronic-Defibrillators, Guidant-Defibrillators, Avandia, Gadolinium Based Contrast Agents, Reglan, Mirena, Actos, Transvaginal mesh implants, Stryker ABG II and Rejuvenate hip implant systems, DePuy ASR and other metal-on-metal hip implants and numerous other cases involving pharmaceuticals and medical devices. For the past 6 years she has been named by California Super Lawyers as a “Rising Star.” She is a member of AAJ’s Leaders Forum, the Reglan/Metoclopramide Litigation Group, and the Stryker Rejuvenate and ABG II Hip Implant Litigation Group. Ms. Abrams is an attorney with Levin Simes, LLP located in San Francisco, California.
Timothy J. Becker, course advisor, concentrates his practice in defective drugs, medical devices, and products litigation. He served on the science team in In re: Zicam Cold Remedy Marketing Sales Practice Litigation, on the law and briefing committee in In re: DePuy Orthopedics, Inc., ASR Hip Implant Products Liability Litigation, and has served as co-lead counsel in several other MDLs, including In re: Zimmer NexGen Knee Products Liability Litigation. He is a member of AAJ’s Leaders Forum, Products Liability Section, and Section on Toxic, Environmental, and Pharmaceutical Torts (STEP), serves on AAJ’s Litigation Group Leaders Council, and has been named to Minnesota’s Super Lawyers. He is also cochair of AAJ’s Propecia/Proscar and Zimmer Knee Litigation Groups. Mr. Becker is a founding partner at Johnson Becker, PLLC in Minneapolis, Minnesota.
Brandon L. Bogle is an associate at the law firm of Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A., in Pensacola, Florida. He concentrates his practice in pharmaceuticals, mass tort, and products liability litigation. Prior to joining Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A., he practiced as an Assistant Public Defender in the Eighteenth and Fourteenth Judicial Circuits, where he was lead counsel in over fifteen jury trials. Mr. Bogle was recognized as instrumental in DUI defense litigation and selected as the Florida Association of Criminal Defense Lawyers DUI scholarship recipient for the Fourteenth Judicial Circuit in 2009. Prior to graduating from the Florida State University College of Law, he worked for the Department of Community Affairs, addressing statewide growth management and land use planning issues.
Derek T. Braslow is a founding partner at Pogust Braslow & Millrood, LLC and has dedicated his career to seeking justice on behalf of individuals and families who have been injured by a defective product, dangerous pharmaceutical drug, or medical device. Mr. Braslow has been voted by his colleagues as a Rising Star and Super Lawyer in the area of pharmaceutical and mass tort litigation in each of the last four years. He has lectured on issues ranging from federal preemption of drug products, antidepressants and suicide, antibiotics and tendon ruptures, clinical trials, bioethics and pharmaceutical litigation and policy. Mr. Braslow is a member of the National Employment Lawyers Association, the Pennsylvania Association for Justice, New Jersey Association for Justice, and the Philadelphia Trial Lawyers Association. He is a member of AAJ’s Leaders Forum, the Preemption Law Litigation Group, the Zimmer Knee Litigation Group, and the Section on Toxic, Environmental, and Pharmaceutical Torts (STEP). Pogust Braslow & Millrood, LLC is located in Conshohocken, Pennsylvania.
Yvonne M. Flaherty, course advisor, concentrates her practice in the areas of complex class action and pharmaceutical and medical device litigation. She serves on AAJ’s National College of Advocacy (NCA) Board of Trustees, is the immediate past chair of AAJ’s Section on Toxic, Environmental & Pharmaceutical Torts (STEP), a member of AAJ’s Leaders Forum, serves as vice chair of AAJ’s Litigation Group Leaders Council, and is a past chair of AAJ’s Women Trial Lawyers Caucus. She also serves on the Minnesota Association for Justice Board of Governors and Executive Committee and is a member of the Minnesota State, Hennepin County, and Federal Bar Associations. She has been appointed by the court to serve on numerous committees in complex litigation involving the Learned Intermediary Doctrine, Claims Review, and Common Benefit Fees. She is a frequent lecturer on a variety of litigation topics, including mass torts, electronic discovery, Daubert, fee agreements, and the learned intermediary doctrine. Lockridge Grindal Nauen P.L.L.P. is located in Minneapolis, Minnesota.
Christopher A. Gomez concentrates his practice in the areas of defective drug, medical device and general product liability claims for individuals, in class actions and in multi-district litigation. Mr. Gomez is a leader of case management, electronic discovery and litigation strategy. His experience includes pre-trial discovery, depositions and first chair in trials. He has conducted settlement negotiations in numerous claims related to Vioxx, Bextra, Zyprexa, Viagra, Fen-Phen, Avandia, Digitek and Phenylpropanolamine (PPA). He is a member of the Pennsylvania State Bar Association, the Virginia State Bar Association, AAJ’s Leaders Forum, and the cochair of the Risperdal Litigation Group. Mr. Gomez practices with Sheller, P.C., located in Philadelphia, Pennsylvania.
Elisha N. Hawk is an associate with Janet, Jenner & Suggs, LLC located in Baltimore, Maryland. She concentrates her practice on products liability and mass tort litigation. Ms. Hawk was honored by the Maryland Super Lawyers by being named a Rising Star for 2013 and 2014. She serves on the Board of Directors for the Maryland Association for Justice (MAJ) Foundation, is MAJ’s Parliamentarian, and chair of MAJ’s New Lawyer Section. She is a member of AAJ’s Leaders Forum, the Pradaxa Litigation Group, Fungal Meningitis Litigation Group, the Transvaginal Mesh Litigation Group, and the Section on Toxic, Environmental, and Pharmaceutical Torts (STEP).).
Claudine Q. Homolash focuses her practice on whistleblower qui tam and drug injury matters. Prior to opening the CQH firm, Ms. Homolash was a partner with Sheller, P.C., focusing on the same practice areas. She worked on the firm’s Avandia, Gadolinium Contrast Dye, Vioxx, Bextra, Celebrex, Medtronic Heart Device, and Guidant Heart Device litigations. Ms. Homolash serves on the Editorial Board of the Legal Intelligencer, and has been recognized by her peers and by legal organizations, including the National Trial Lawyers as a “Top 40 Under 40” attorney in Pennsylvania. She has been recognized as a Pennsylvania Super Lawyer in 2013, as well as a Pennsylvania Rising Star in 2010, 2011, and 2012 by the national Super Lawyer organization. Ms. Homolash is a member of the Preemption Law Litigation Group and the cochair of the Risperdal Litigation Group. CQH Firm is located in Philadelphia, Pennsylvania.
Robert K. Jenner, course advisor, concentrates his practice in prescription drug and defective medical device litigation. He is listed in Maryland’s Super Lawyers and was recently named Best Lawyers 2013 “Lawyer of the Year” and Baltimore Mass Tort Litigation/Class Actions—Plaintiffs “Lawyer of the Year.” Mr. Jenner is a past president of Maryland Association for Justice (MAJ), serves on its Board of Governors, and was awarded MAJ’s Trial Lawyer of the Year Award (2009). Mr. Jenner is a member of AAJ’s Leaders Forum, cochair of AAJ’s Pain Pump−Chondrolysis Litigation Group, and is chair of AAJ’s Publications Committee. He is currently co-lead counsel of the toning shoes MDL (In re: Skechers Toning Shoe Products Liability Litigation); and co-lead counsel for the Massachusetts state consolidation of GranuFlo cases (In re: Consolidated Fresenius Cases). Mr. Jenner works out of the Janet, Jenner & Suggs, LLC Baltimore, Maryland office where he leads the firm’s Mass Tort Department.
Seth A. Katz concentrates his practice in the areas of complex, pharmaceutical mass tort, and class action litigation including consumer protection, securities fraud, products liability, and commercial litigation. Mr. Katz serves as co-lead counsel in the multidistrict litigation In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385. He is the former president of the Mass Tort Trial Lawyers Association (MTTLA) and a member of the Colorado Trial Lawyers Association. He is a member of AAJ’s Leader Forum, Depuy Metal on Metal Hip Implant Litigation Group, Preemption Law Litigation Group, and Class Action Litigation Group. Mr. Katz is a shareholder in the Englewood, Colorado office of Burg Simpson Eldredge Hersh & Jardine, P.C.
Peter Kaufman is an attorney with Panish, Shea & Boyle LLP, located in Los Angeles, California. Mr. Kaufman concentrates his practice in mass tort pharmaceutical and medical device litigation. He currently serves as the cochair of the Trial Package Committee for the Vioxx Multi-District Litigation (MDL). Mr. Kaufman is a frequent speaker on pharmaceutical litigation, covering topics such as scientific evidence, trial preparation, and case selection criteria. In the past, he was a frequent contributor to GoLeft.TV and served as Legal Counsel for the World Alliance of Mixed Martial Arts (WAMMA). Mr. Kauffman is an AAJ Leaders Forum member.
Joseph M. Lyon founded the The Lyon Firm, located in Cincinnati, Ohio. His practice areas include medical malpractice, pharmaceutical defects, medical device defects, automotive defects, class action and mass tort litigation, commercial and business litigation and general personal injury matters. Mr. Lyon served on AAJ’s Board of Governors, is the cochair of the Testosterone Therapy Litigation Group, and a member of the Products Liability Section and the Section on Toxic, Environmental, and Pharmaceutical Torts (STEP). He is a member of the Cincinnati Bar Association, Ohio State Bar Association, American Trial Lawyers Association, and the American Constitution Society.
Karen Barth Menzies, course advisor, concentrates her practice in plaintiffs’ pharmaceutical mass tort and consumer class actions. She served as the lead plaintiffs’ counsel in the Paxil MDL, Central District of California. She is currently a member of the Plaintiffs’ Steering Committee for the Avandia MDL, Eastern District of Pennsylvania, and coliaison counsel for the Paxil Birth Defects litigation pending in Philadelphia. She is currently the cochair of the Commercial and Marketing Committee for the Zoloft MDL, co-lead counsel for the Lexapro/Celexa cases coordinated in Missouri state court, and lead counsel for the Fosamax litigation coordinated in the Philadelphia Court of Common Pleas. She is cochair of AAJ’s DePuy Metal on Metal Hip Implant Litigation Group and a member of AAJ’s Leaders Forum. Ms. Menzies has testified three times before the FDA and also before the California State Senate regarding the risks of pharmaceutical drugs. She has published numerous articles and speaks on preemption, FDA, and pharmaceutical drug risks to both legal and medical organizations. She is a partner at the law firm of Robinson Calcagnie Robinson Shapiro Davis, Inc. in Newport Beach, California, with offices in Los Angeles and San Bernardino, California.
Tobias L. Millrood, course advisor, concentrates his practice in numerous mass torts, including Fen-Phen, Vioxx, Baycol, Meridia, thimerosal, ephedra, and hormone therapy. Mr. Millrood served as liaison counsel in the consolidated Hormone Therapy Mass Tort Litigation in Philadelphia County. Mr. Millrood is a prior member of the Board of Governors of the Pennsylvania Association for Justice (formerly the Pennsylvania Trial Lawyers Association) (PAJ), a member of PAJ, past chair of AAJ’s Hormone Therapy Litigation Group, chair of AAJ’s Section and Litigation Group Coordination Committee, and AAJ’s Board of Governors. He is a member of AAJ’s Leaders Forum. He is a frequent speaker at various seminars on the topic of mass tort litigation, hormone therapy, cardiac device litigation, and the ethics of settling mass tort cases. Mr. Millrood is a partner in the firm Pogust Braslow & Millrood in Conshohocken, Pennsylvania.
Trent B. Miracle concentrates his practice in prescription drug and defective medical device litigation. He is a shareholder at Simmons Browder Gianaris Angelides and Barnerd LLC, located in Alton, Illinois, where he heads the firm’s pharmaceutical litigation department. Mr. Miracle serves on the Plaintiffs’ Steering Committees for MDL No. 2100 In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation and MDL 2244 In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation and is currently co-lead in MDL No. 2331 In Re: Propecia (Finasteride) Products Liability Litigation. He is a past cochair of AAJ’s Asbestos Litigation group and current co-chair of AAJ’s Testosterone Therapy Litigation Group.
Robert A. Mosier is a trial lawyer with the law firm of Sanders Viener Grossman, LLP in Los Angeles, California. Mr. Mosier’s practice is focused on representing plaintiffs harmed by pharmaceutical and medical device companies. He also maintains an active medical malpractice caseload. Mr. Mosier currently represents clients injured by Tylenol, Risperdal, Medtronic Infuse, Reglan, Crestor, Granuflo, Pain Pumps, Transvaginal Mesh, DePuy ASR, Pinnacle Hips, Januvia, Byetta, and Yaz. He serves as plaintiffs’ liaison counsel in the In Re: Infusion Pain Pump (JCCP 4615) litigation, the Plaintiffs’ Steering Committee in the In Re: Incretin Mimetics Product Liability Litigation, MDL 2452, and the Science Committee in the In Re: Fresenius Granuflo/Naturalyte Dialysate Products, MDL 2428. Mr. Mosier is also a speaker at national legal conventions on various issues involving mass tort litigation. He is an AV Preeminent Attorney, a member of the Million Dollar Advocates Forum, and was named one of National Trial Lawyers top 100 attorneys. He is an AAJ Leaders Forum member, cochair of the Risperdal Litigation Group, and member of the Dialysis Equipment, Products and Clinics Litigation Group, and the Medtronic INFUSE Litigation Group.
Daniel S. Robinson is partner in the Newport Beach office of Robinson Calcagnie Robinson Shapiro Davis, Inc., concentrating in civil litigation. In 2011, the Orange County Trial Lawyers Association (OCTLA) awarded Mr. Robinson the 2011 OCTLA Young Gun Award. He has been recognized as a Super Lawyer and has been appointed to the plaintiffs’ executive committee for the federal multidistrict proceeding for the Contaminated Heparin Litigation, MDL 1953, the plaintiffs’ steering committee in the In re: Actos Product Liability Cases, and the plaintiffs’ steering committee in the In re: Fosamax/Alendronate Sodium Drug Cases. Mr. Robinson is a past cochair of AAJ’s Yaz/Yasmin Litigation Group and is a member of AAJ’s Litigation Group Leaders Council and Leaders Forum.
Navan Ward Jr. concentrates his practice in pharmaceutical and nursing home litigation. Mr. Ward has lectured on hip replacement, Cox-2 drug, Permax/Ostinex litigation, hormone replacement therapy litigation, and nursing home litigation issues throughout the country. He was selected to the Plaintiffs’ Steering Committee for the DePuy Hip Implant Recall MDL and the Plaintiffs’ Steering Committee for the Pinnacle Hip Replacement MDL. He serves as cochair for AAJ’s DePuy Metal on Metal Hip Implant Litigation Group, the vice president for the Young Lawyers Section of the Alabama State Bar, vice president for the Montgomery County Trial Lawyers Association, treasurer for the Capital City Bar Association, president for the Alabama Lawyers’ Association, and is a member of AAJ’s Leaders Forum. Mr. Ward is a member of the Montgomery County Bar Association, the Mississippi Bar Association, and is an American Bar Association State Delegate for Alabama. He is a shareholder in the firm Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. located in Montgomery, Alabama.